🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Timm O. Koller

Universität Hamburg

ORCID: 0000-0003-0145-4891

Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyEnvironmental Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “The Myxobacterial Antibiotic Myxovalargin: Biosynthesis, Structural Revision, Total Synthesis, and Molecular Characterization of Ribosomal Inhibition”.

The Myxobacterial Antibiotic Myxovalargin: Biosynthesis, Structural Revision, Total Synthesis, and Molecular Characterization of Ribosomal Inhibition

Journal of the American Chemical Society(2023)10.1021/jacs.2c08816

N/A

0.405DataRank · unranked

9 citations

Ullrich Scheid, Teresa Kösel, Jennifer Herrmann, Daniel Krug, Helena I. Boshoff +28 more

Paenilamicins are context-specific translocation inhibitors of protein synthesis

Nature Chemical Biology(2024)10.1038/s41589-024-01752-9

N/A

0.391DataRank · unranked

10 citations

Max Berger, Martino Morici, Helge Paternoga, Timur M. Bulatov, Adriana Di Stasi +12 more

Context-specific action of macrolide antibiotics on the eukaryotic ribosome

Nature Communications(2021)10.1038/s41467-021-23068-1

N/A

0DataRank · unranked

37 citations

Timm O. Koller, Sezen Meydan, Vaishnavi Shankar, Dorota Klepacki, Norbert Polacek +5 more

The myxobacterial antibiotic myxovalargin: Biosynthesis, structural revision, total synthesis and molecular characterization of ribosomal inhibition

ChemRxiv(2022)10.26434/chemrxiv-2022-vr3hn

N/A

0DataRank · unranked

0 citations

Ullrich Scheid, Teresa Kösel, Jennifer Herrmann, Daniel Krug, Helena I. Boshoff +22 more